| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4801 | 2005 |
| Comprehensive genomic profiles of small cell lung cancer J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ... Nature 524 (7563), 47-53, 2015 | 2039 | 2015 |
| Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer M Peifer, L Fernández-Cuesta, ML Sos, J George, D Seidel, LH Kasper, ... Nature genetics 44 (10), 1104-1110, 2012 | 1480 | 2012 |
| Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1279 | 2007 |
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma R Beroukhim, G Getz, L Nghiemphu, J Barretina, T Hsueh, D Linhart, ... Proceedings of the National Academy of Sciences 104 (50), 20007-20012, 2007 | 1238 | 2007 |
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ... Nature genetics 41 (11), 1238-1242, 2009 | 1070 | 2009 |
| Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer J Weiss, ML Sos, D Seidel, M Peifer, T Zander, JM Heuckmann, RT Ullrich, ... Science translational medicine 2 (62), 62ra93-62ra93, 2010 | 1005 | 2010 |
| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011 | 951 | 2011 |
| TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, SR Setlur, ... Oncogene 26 (31), 4596-4599, 2007 | 835 | 2007 |
| TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ... Cancer research 66 (17), 8337-8341, 2006 | 670 | 2006 |
| Telomerase activation by genomic rearrangements in high-risk neuroblastoma M Peifer, F Hertwig, F Roels, D Dreidax, M Gartlgruber, R Menon, ... Nature 526 (7575), 700-704, 2015 | 615 | 2015 |
| Prevention and early detection of prostate cancer J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ... The lancet oncology 15 (11), e484-e492, 2014 | 602 | 2014 |
| TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion S Perner, JM Mosquera, F Demichelis, MD Hofer, PL Paris, J Simko, ... The American journal of surgical pathology 31 (6), 882-888, 2007 | 564 | 2007 |
| Prostate-specific membrane antigen expression as a predictor of prostate cancer progression S Perner, MD Hofer, R Kim, RB Shah, H Li, P Möller, RE Hautmann, ... Human pathology 38 (5), 696-701, 2007 | 562 | 2007 |
| Gleason score and lethal prostate cancer: does 3+ 4= 4+ 3? JR Stark, S Perner, MJ Stampfer, JA Sinnott, S Finn, AS Eisenstein, J Ma, ... Journal of Clinical Oncology 27 (21), 3459-3464, 2009 | 455 | 2009 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 399 | 2008 |
| Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer SR Setlur, KD Mertz, Y Hoshida, F Demichelis, M Lupien, S Perner, ... Journal of the National Cancer Institute 100 (11), 815-825, 2008 | 388 | 2008 |
| Imaging prostate cancer with 11C-choline PET/CT SN Reske, NM Blumstein, B Neumaier, HW Gottfried, F Finsterbusch, ... Journal of Nuclear Medicine 47 (8), 1249-1254, 2006 | 359 | 2006 |
| EML4-ALK fusion lung cancer: a rare acquired event S Perner, PL Wagner, F Demichelis, R Mehra, CJ LaFargue, BJ Moss, ... Neoplasia 10 (3), 298-302, 2008 | 320 | 2008 |
| Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer CM Lovly, NT McDonald, H Chen, S Ortiz-Cuaran, LC Heukamp, Y Yan, ... Nature medicine 20 (9), 1027-1034, 2014 | 299 | 2014 |
